REGISTRIES: Innovaderm ANB019-401
adminmderm2022-03-04T15:18:43+00:00ANB019-401: An international, multicenter, prospective registry of patients with generalized pustular psoriasis (GPP). Clinical trial for adults (age > 18) with clinically confirmed diagnosis [...]
ATOPIC DERMATITIS: ASLAN004-003
Cristina Martinez2022-03-29T20:32:51+00:00ASLAN004-003: A randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe atopic dermatitis. [...]
Am I forced to finish a clinical trial once I start?
adminmderm2021-06-02T16:08:06+00:00No, your participation is voluntary and you are free to withdraw from trial at any time. Before consenting to participate in a clinical trial the [...]
What is a Registry?
adminmderm2021-06-02T16:07:18+00:00This is an observational study where patients are followed to track treatments (medications, efficacy, length of time used), side effects, complications, and other medications & [...]
What is a long-term extension?
adminmderm2021-05-25T17:40:41+00:00A long-term extension follows an initial study. All patients on these studies will receive medications, typically for a longer time period of one to several [...]
How we measure body surface area (BSA)?
adminmderm2021-06-22T20:36:32+00:00BSA is determined by measuring the number of handprints of involvement present. A handprint includes the palm and the fingers as shown in the image. [...]
What is a placebo?
adminmderm2021-06-02T16:06:00+00:00A placebo is a treatment containing all compounds present in the investigational product except the active ingredient. It is necessary in clinical trials to [...]
Will MDRI diagnose my condition?
adminmderm2021-05-25T17:37:20+00:00Typically studies will require a clinical diagnosis prior to enrollment, and will request medical records from patients to affirm the date of diagnosis. [...]